AI Article Synopsis
- seems like I can't see the figure or text you're referring to. However, if you provide a summary or key points from the text, I can help you create a synopsis! Just let me know what details you have in mind.
Article Abstract
[Figure: see text].
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7946728 | PMC |
| http://dx.doi.org/10.1161/HYPERTENSIONAHA.120.16336 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Tubular MYDGF Slows Progression of Chronic Kidney Disease by Maintaining Mitochondrial Homeostasis.
Adv Sci (Weinh)
November 2024
Department of Pharmacology, School of Basic Medical Sciences, Shandong University, Jinan, 250012, China.
Mitochondrial dysfunction is a key event driving the maladaptive repair of tubular epithelial cells during the transition from acute kidney injury to chronic kidney disease (CKD). Therefore, identifying potential targets involved in mitochondrial dysfunction in tubular epithelial cells is clinically important. Myeloid-derived growth factor (MYDGF), a novel secreted protein, plays important roles in multiple cardiovascular diseases, but the function of MYDGF in tubular epithelial cells remains unknown.
View Article and Find Full Text PDFTET2 germline variants promote kidney disease by impairing DNA repair and activating cytosolic nucleotide sensors.
Nat Commun
November 2024
Renal, Electrolyte, and Hypertension Division, Department of Medicine, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.
Genome-wide association studies (GWAS) have identified over 800 loci associated with kidney function, yet the specific genes, variants, and pathways involved remain elusive. By integrating kidney function GWAS with human kidney expression and methylation quantitative trait analyses, we identified Ten-Eleven Translocation (TET) DNA demethylase 2 (TET2) as a novel kidney disease risk gene. Utilizing single-cell chromatin accessibility and CRISPR-based genome editing, we highlight GWAS variants that influence TET2 expression in kidney proximal tubule cells.
View Article and Find Full Text PDFDeletion of AT receptors selectively in the proximal tubules of the kidney alters the hypotensive and natriuretic response to atrial natriuretic peptide via NPR/cGMP/NO signaling.
Am J Physiol Renal Physiol
December 2024
Tulane Hypertension and Renal Center of Excellence and Department of Physiology, Tulane University School of Medicine, New Orleans, Louisiana, United States.
In the proximal tubules of the kidney, angiotensin II (ANG II) binds and activates ANG II type 1 (AT) receptors to stimulate proximal tubule Na reabsorption, whereas atrial natriuretic peptide (ANP) binds and activates natriuretic peptide receptors (NPR) to inhibit ANG II-induced proximal tubule Na reabsorption. These two vasoactive systems play important counteracting roles to control Na reabsorption in the proximal tubules and help maintain blood pressure homeostasis. However, how AT and NPR receptors interact in the proximal tubules and whether natriuretic effects of NPR receptor activation by ANP may be potentiated by deletion of AT (AT) receptors selectively in the proximal tubules have not been studied previously.
View Article and Find Full Text PDFSustained alterations in proximal tubule gene expression in primary culture associate with HNF4A loss.
Sci Rep
October 2024
Division of Nephrology, Department of Internal Medicine, University of Michigan, 1500 E. Medical Center Drive, SPC 5364, Ann Arbor, MI, 48109, USA.
Primary cultures of proximal tubule cells are widely used to model the behavior of kidney epithelial cells in vitro. However, de-differentiation of primary cells upon culture has been observed and appreciated for decades, yet the mechanisms driving this phenomenon remain poorly understood. This confounds the interpretation of experiments using primary kidney epithelial cells and prevents their use to engineer functional kidney tissue ex vivo.
View Article and Find Full Text PDFArticle Synopsis
- Acute kidney injury (AKI) is characterized by a rapid decrease in kidney function due to various causes, and the role of the transcription factor PRDM16 in this condition is being researched.
- PRDM16 was found to inhibit cell death caused by ischemia/reperfusion injury in kidney cells by regulating the expression of S100A6 and targeting specific signaling pathways.
- In experiments, PRDM16 showed protective effects against AKI, while its absence worsened the condition in genetically modified mice, indicating its potential as a therapeutic target.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!